FOXO3 and cancer: Moreover, recent studies demonstrated that inactivation of FOXO3a can induce epithelial-to-mesenchymal transition (EMT) and subsequently promote cancer cell invasion and dissemination, indicating that FOXO3a can act as a potential biomarker for the prediction and therapy of cancer metastasis [7–11].